These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20713596)

  • 101. Liver-expressed
    Brown RJP; Tegtmeyer B; Sheldon J; Khera T; Anggakusuma ; Todt D; Vieyres G; Weller R; Joecks S; Zhang Y; Sake S; Bankwitz D; Welsch K; Ginkel C; Engelmann M; Gerold G; Steinmann E; Yuan Q; Ott M; Vondran FWR; Krey T; Ströh LJ; Miskey C; Ivics Z; Herder V; Baumgärtner W; Lauber C; Seifert M; Tarr AW; McClure CP; Randall G; Baktash Y; Ploss A; Thi VLD; Michailidis E; Saeed M; Verhoye L; Meuleman P; Goedecke N; Wirth D; Rice CM; Pietschmann T
    Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148654
    [TBL] [Abstract][Full Text] [Related]  

  • 102. HCV Spread Kinetics Reveal Varying Contributions of Transmission Modes to Infection Dynamics.
    Durso-Cain K; Kumberger P; Schälte Y; Fink T; Dahari H; Hasenauer J; Uprichard SL; Graw F
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372514
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Hepatitis C virus and neutralizing antibodies].
    Fauvelle C; Heydmann L; Zeisel MB; Baumert TF; Stoll-Keller F; Fafi-Kremer S
    Virologie (Montrouge); 2011 Oct; 15(5):326-336. PubMed ID: 36151691
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Heterogeneous claudin-1 expression in human liver.
    Harris HJ; Wilson GK; Hübscher SG; McKeating JA
    Hepatology; 2013 Feb; 57(2):854-5. PubMed ID: 22807091
    [No Abstract]   [Full Text] [Related]  

  • 105. SMAD About Hepatitis C Virus Cell Entry and Liver Disease.
    Colpitts CC; Baumert TF
    Gastroenterology; 2017 Jan; 152(1):21-23. PubMed ID: 27889572
    [No Abstract]   [Full Text] [Related]  

  • 106. Flunarizine arrests hepatitis C virus membrane fusion.
    Prigozhin DM; Modis Y
    Hepatology; 2016 Jan; 63(1):14-6. PubMed ID: 26389725
    [No Abstract]   [Full Text] [Related]  

  • 107. Hepatitis C Virus and Molecular Mimicry.
    Goh L; Kerkar N
    Pathogens; 2024 Jun; 13(7):. PubMed ID: 39057754
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.
    Tawar RG; Colpitts CC; Timm J; Fehm T; Roggendorf M; Meisel H; Meyer N; Habersetzer F; Cosset FL; Berg T; Zeisel MB; Baumert TF
    Hepatology; 2015 Sep; 62(3):726-36. PubMed ID: 26010076
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir.
    Donaldson EF; Harrington PR; O'Rear JJ; Naeger LK
    Hepatology; 2015 Jan; 61(1):56-65. PubMed ID: 25123381
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423.
    Keck ZY; Angus AG; Wang W; Lau P; Wang Y; Gatherer D; Patel AH; Foung SK
    PLoS Pathog; 2014 Aug; 10(8):e1004297. PubMed ID: 25122476
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Global distribution and prevalence of hepatitis C virus genotypes.
    Messina JP; Humphreys I; Flaxman A; Brown A; Cooke GS; Pybus OG; Barnes E
    Hepatology; 2015 Jan; 61(1):77-87. PubMed ID: 25069599
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
    Xiao F; Fofana I; Heydmann L; Barth H; Soulier E; Habersetzer F; Doffoël M; Bukh J; Patel AH; Zeisel MB; Baumert TF
    PLoS Pathog; 2014 May; 10(5):e1004128. PubMed ID: 24830295
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Structural analysis of hepatitis C virus core-E1 signal peptide and requirements for cleavage of the genotype 3a signal sequence by signal peptide peptidase.
    Oehler V; Filipe A; Montserret R; da Costa D; Brown G; Penin F; McLauchlan J
    J Virol; 2012 Aug; 86(15):7818-28. PubMed ID: 22593157
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.
    Lacek K; Vercauteren K; Grzyb K; Naddeo M; Verhoye L; Słowikowski MP; Fafi-Kremer S; Patel AH; Baumert TF; Folgori A; Leroux-Roels G; Cortese R; Meuleman P; Nicosia A
    J Hepatol; 2012 Jul; 57(1):17-23. PubMed ID: 22414763
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.
    Brown KS; Keogh MJ; Owsianka AM; Adair R; Patel AH; Arnold JN; Ball JK; Sim RB; Tarr AW; Hickling TP
    Protein Cell; 2010 Jul; 1(7):664-74. PubMed ID: 21203938
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors.
    Sahin M; Remy MM; Fallet B; Sommerstein R; Florova M; Langner A; Klausz K; Straub T; Kreutzfeldt M; Wagner I; Schmidt CT; Malinge P; Magistrelli G; Izui S; Pircher H; Verbeek JS; Merkler D; Peipp M; Pinschewer DD
    Cell Rep; 2022 Feb; 38(5):110303. PubMed ID: 35108544
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A Role for B Cells to Transmit Hepatitis C Virus Infection.
    Desombere I; Van Houtte F; Farhoudi A; Verhoye L; Buysschaert C; Gijbels Y; Couvent S; Swinnen W; Van Vlierberghe H; Elewaut A; Magri A; Stamataki Z; Meuleman P; McKeating JA; Leroux-Roels G
    Front Immunol; 2021; 12():775098. PubMed ID: 34975862
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Therapy Implications of Hepatitis C Virus Genetic Diversity.
    Martinez MA; Franco S
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33383891
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Antibody Responses in Hepatitis C Infection.
    Law M
    Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32341067
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies.
    Walker MR; Leung P; Eltahla AA; Underwood A; Abayasingam A; Brasher NA; Li H; Wu BR; Maher L; Luciani F; Lloyd AR; Bull RA
    Sci Rep; 2019 Sep; 9(1):13300. PubMed ID: 31527718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.